Who has invested in eNeura Therapeutics?

Catalio Capital Management are named among the investors backing eNeura Therapeutics.

eNeura Therapeutics Funding: $17M Raised, Series D (2018)

eNeura Therapeutics funding overview

eNeura Therapeutics is based in Washington, D.C.. eNeura Therapeutics has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series D announced in February 2018. The round record for eNeura Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Catalio Capital Management.

eNeura Therapeutics at a glance

Total raised: $17M
Latest round: Series D
Latest round date: February 2018
Headquarters: Washington, D.C.
Notable investors: Catalio Capital Management

Frequently asked about eNeura Therapeutics funding

How much has eNeura Therapeutics raised?: eNeura Therapeutics has raised $17M in total disclosed funding across the rounds on record.
Who has invested in eNeura Therapeutics?: Catalio Capital Management are named among the investors backing eNeura Therapeutics.
What was the latest eNeura Therapeutics funding round?: The most recent disclosed round is a Series D, announced in February 2018.
Where is eNeura Therapeutics based?: eNeura Therapeutics is based in Washington, D.C..
When did eNeura Therapeutics last raise?: The last disclosed eNeura Therapeutics round closed in February 2018 at Series D.

We update the eNeura Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Washington and their backers are listed below.

eNeura Therapeutics Funding: $17M Raised, Series D (2018)

eNeura Therapeutics funding overview

eNeura Therapeutics at a glance

Frequently asked about eNeura Therapeutics funding

Companies related to eNeura Therapeutics (36)

Browse related funding lists (4)